REQUEST A DEMO
Total
USD $0.00
Search more companies

Sopharmacy 41 EOOD (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Sopharmacy 41 EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Sopharmacy 41 EOOD is based in Bulgaria. The head office is in Sofia. The company operates in the Pharmacies and Drug Stores industry. The company was established on 2021. 28 (2023) employees currently work for Sopharmacy 41 EOOD. The company’s latest financial report indicates a net sales revenue drop of 22.63% in 2022. Its’ total assets recorded a growth of 0.71%.

Headquarters
Lachezar Stanchev 5 Sofarma Biznes Tauars Sgrada A et. 13
Sofia; Sofia - city; Postal Code: 1756

Contact Details: Purchase the Sopharmacy 41 EOOD report to view the information.

Basic Information
Total Employees:
Purchase the Sopharmacy 41 EOOD report to view the information.
Outstanding Shares:
Purchase the Sopharmacy 41 EOOD report to view the information.
Registered Capital:
Purchase the Sopharmacy 41 EOOD report to view the information.
Incorporation Date:
2021
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sopharmacy 41 EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-22.63%
Total operating revenue
-22.38%
Net Profit (Loss) for the Period
N/A
Total assets
0.71%
Total equity
N/A
Operating Profit Margin (ROS)
0.86%
Net Profit Margin
N/A
Return on Equity (ROE)
356.78%
Quick Ratio
0.55%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?